Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Modulation of Peanut-specific humoral and cellular responses pre- and post-oral immunotherapy.

Kwok WW.

Clin Exp Allergy. 2015 Jul;45(7):1146-9. doi: 10.1111/cea.12552. No abstract available.

PMID:
26082305
2.

Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.

Wisniewski JA, Commins SP, Agrawal R, Hulse KE, Yu MD, Cronin J, Heymann PW, Pomes A, Platts-Mills TA, Workman L, Woodfolk JA.

Clin Exp Allergy. 2015 Jul;45(7):1201-13. doi: 10.1111/cea.12537.

3.

The immunoglobulin superfamily member CD200R identifies cells involved in type 2 immune responses.

Blom LH, Martel BC, Larsen LF, Hansen CV, Christensen MP, Juel-Berg N, Litman T, Poulsen LK.

Allergy. 2017 Jul;72(7):1081-1090. doi: 10.1111/all.13129. Epub 2017 Feb 21.

PMID:
28106273
4.

Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses.

Prussin C, Lee J, Foster B.

J Allergy Clin Immunol. 2009 Dec;124(6):1326-32.e6. doi: 10.1016/j.jaci.2009.09.048.

5.

Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector TH2 subsets.

Chiang D, Chen X, Jones SM, Wood RA, Sicherer SH, Burks AW, Leung DYM, Agashe C, Grishin A, Dawson P, Davidson WF, Newman L, Sebra R, Merad M, Sampson HA, Losic B, Berin MC.

J Allergy Clin Immunol. 2018 Jun;141(6):2107-2120. doi: 10.1016/j.jaci.2017.11.060. Epub 2018 Jan 31.

6.

Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model.

Feng BS, Chen X, He SH, Zheng PY, Foster J, Xing Z, Bienenstock J, Yang PC.

J Allergy Clin Immunol. 2008 Jul;122(1):55-61, 61.e1-7. doi: 10.1016/j.jaci.2008.04.036. Epub 2008 Jun 10.

PMID:
18547633
7.

Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.

van Wijk F, Hartgring S, Koppelman SJ, Pieters R, Knippels LM.

Clin Exp Allergy. 2004 Sep;34(9):1422-8.

PMID:
15347376
8.

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.

Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Dupont C, Benhamou PH.

Clin Exp Allergy. 2014 Jun;44(6):867-81. doi: 10.1111/cea.12312.

9.

Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function.

Wang M, Han J, Domenico J, Shin YS, Jia Y, Gelfand EW.

Allergy. 2016 Nov;71(11):1561-1574. doi: 10.1111/all.12904. Epub 2016 Aug 3.

10.

Hepatic Mitochondrial Dysfunction and Immune Response in a Murine Model of Peanut Allergy.

Trinchese G, Paparo L, Aitoro R, Fierro C, Varchetta M, Nocerino R, Mollica MP, Berni Canani R.

Nutrients. 2018 Jun 8;10(6). pii: E744. doi: 10.3390/nu10060744.

11.

Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2.

Glaspole IN, de Leon MP, Rolland JM, O'Hehir RE.

Allergy. 2005 Jan;60(1):35-40.

PMID:
15575928
12.

Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.

Srivastava KD, Qu C, Zhang T, Goldfarb J, Sampson HA, Li XM.

J Allergy Clin Immunol. 2009 Feb;123(2):443-51. doi: 10.1016/j.jaci.2008.12.1107.

PMID:
19203662
13.

B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines.

Admyre C, Bohle B, Johansson SM, Focke-Tejkl M, Valenta R, Scheynius A, Gabrielsson S.

J Allergy Clin Immunol. 2007 Dec;120(6):1418-24. Epub 2007 Sep 14.

PMID:
17868797
14.

Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.

Srivastava KD, Siefert A, Fahmy TM, Caplan MJ, Li XM, Sampson HA.

J Allergy Clin Immunol. 2016 Aug;138(2):536-543.e4. doi: 10.1016/j.jaci.2016.01.047. Epub 2016 Apr 26.

PMID:
27130858
15.

Experimental food allergy to peanut enhances the immune response to house dust mite in the airways of mice.

Utsch L, Logiantara A, van Ree R, van Rijt LS.

Clin Exp Allergy. 2017 Jan;47(1):121-128. doi: 10.1111/cea.12799. Epub 2016 Sep 20.

PMID:
27533916
16.

Therapeutic effects of a fermented soy product on peanut hypersensitivity is associated with modulation of T-helper type 1 and T-helper type 2 responses.

Zhang T, Pan W, Takebe M, Schofield B, Sampson H, Li XM.

Clin Exp Allergy. 2008 Nov;38(11):1808-18. doi: 10.1111/j.1365-2222.2008.03075.x. Epub 2008 Aug 13.

17.

Chemical modification of peanut conglutin reduces IgE reactivity but not T cell reactivity in peanut-allergic patients.

van Hoffen E, van der Kleij HP, den Hartog Jager CF, van Doorn WA, Knol EF, Opstelten DJ, Koppelman SJ, Knulst AC.

Clin Exp Allergy. 2014 Dec;44(12):1558-66. doi: 10.1111/cea.12319.

PMID:
24717146
18.

Oral administration of chitin and chitosan prevents peanut-induced anaphylaxis in a murine food allergy model.

Bae MJ, Shin HS, Kim EK, Kim J, Shon DH.

Int J Biol Macromol. 2013 Oct;61:164-8. doi: 10.1016/j.ijbiomac.2013.06.017. Epub 2013 Jun 24.

PMID:
23806320
19.

Changes in peanut-specific T-cell clonotype with oral immunotherapy.

B├ęgin P, Nadeau KC.

J Allergy Clin Immunol. 2015 Jun;135(6):1636-8. doi: 10.1016/j.jaci.2015.03.010. Epub 2015 Apr 28. No abstract available.

PMID:
25930192
20.

A novel model of sensitization and oral tolerance to peanut protein.

Strid J, Thomson M, Hourihane J, Kimber I, Strobel S.

Immunology. 2004 Nov;113(3):293-303.

Supplemental Content

Support Center